As demand for copper surges due to AI data centers and electric vehicles, Giraffe Bio has secured $6.4 million to engineer customized biomolecules that enhance copper recovery by up to 5% in existing mines, potentially easing the looming supply crunch.
- Copper supply may fall 25% short of demand by 2040.
- Giraffe Bio’s biomolecules enhance copper mining recovery by up to 5%.
- The startup raised $6.4 million led by Orion Industrial Ventures.
What happened
Giraffe Bio, a startup focused on mining biotechnology, has closed a $6.4 million seed funding round to advance its platform for improving copper extraction. The funding round was led by Orion Industrial Ventures with support from mining industry and venture investors including BHP Ventures. Giraffe Bio’s technology produces mine-specific chemicals using engineered microbes in bioreactors, which are then applied to flotation processes to recover more copper from ores.
Unlike approaches deploying live microbes in harsh mining environments, Giraffe Bio creates bespoke biomolecules that specifically bind copper while minimizing uptake of unwanted minerals. Their technology can boost copper recovery by up to 5%, a significant improvement over the typical 1-2% gains miners accept. The company is also developing similar biomolecules to target other minerals and reduce the use of toxic flotation chemicals.
Why it matters
The global surge in demand for copper, driven by the growth of AI data centers and the shift to electric vehicles, is expected to create a supply shortfall of around 25% by 2040. Increasing mine output by discovering new deposits is expensive, slow, and uncertain, as only a tiny fraction of prospects become viable mines. Enhancing recovery from existing operations offers a quicker, cost-effective way to increase supply.
Giraffe Bio’s biotech solution addresses this challenge by improving the efficiency and environmental footprint of copper extraction. By replacing harmful chemicals with targeted biomolecules, the technology could reduce environmental damage associated with mining processes. Additionally, the ability to tailor compounds to each mine's mineralogy helps maximize resource recovery, extending the lifespan and productivity of existing mines.
What to watch next
Giraffe Bio is currently scaling up its technology and working to validate its biomolecules in commercial mining operations. Key developments to watch include pilot projects demonstrating recovery improvements and environmental benefits, as well as the startup’s expansion into other critical minerals beyond copper, such as gold and silver.
Investor interest in mining biotech is growing alongside global pressure to secure critical mineral supplies sustainably. Giraffe Bio’s progress and partnerships with established mining firms will be important indicators of how biotech innovation can reshape the sector, potentially setting new standards for mineral extraction in an era of increasing demand and environmental regulation.